Also trades as: 0GX2.L (LSE) · $vol 0M
NRO.PA PAR
Neurones S.A.
1W: -4.9%
1M: -3.0%
3M: -2.6%
YTD: -10.1%
1Y: -12.3%
3Y: -1.5%
5Y: +10.9%
€35.20 ($39.60)
-0.65 (-1.81%)
Weekly Expected Move ±4.0%
€32
€34
€35
€37
€38
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$857M
+5.8% ▲
5Y CAGR: +10.3%
Gross Profit
$0
-100.0% ▼
Operating Income
$76M
-3.0% ▼
5Y CAGR: +7.8%
Net Income
$62M
+17.9% ▲
5Y CAGR: +14.9%
EPS (Diluted)
$2.14
-0.9% ▼
5Y CAGR: +11.0%
EBITDA
$76M
-12.0% ▼
5Y CAGR: +1.9%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $580M | $665M | $741M | $810M | $857M |
| YoY Growth | +10.6% | +14.7% | +11.4% | +9.3% | +5.8% |
| Cost of Revenue | $510M | $584M | $394M | $422M | $0 |
| Gross Profit | $70M | $82M | $347M | $389M | $0 |
| Gross Margin | 12.0% | 12.3% | 46.8% | 48.0% | 0.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $171M | -$11M | $249M | $304M | $0 |
| Operating Expenses | $195M | $236M | $271M | $311M | $782M |
| Operating Income | $62M | $73M | $76M | $78M | $76M |
| Operating Margin | 10.6% | 11.0% | 10.2% | 9.6% | 8.8% |
| Interest Expense | $966K | $2M | $1M | $2M | $0 |
| Income Before Tax | $62M | $73M | $81M | $88M | $85M |
| Tax Expense | $19M | $21M | $22M | $25M | $23M |
| Net Income | $38M | $44M | $49M | $52M | $62M |
| Net Margin | 6.5% | 6.6% | 6.7% | 6.5% | 7.2% |
| EPS (Diluted) | $1.56 | $1.82 | $2.03 | $2.16 | $2.14 |
| EBITDA | $76M | $89M | $97M | $86M | $76M |
| Shares Outstanding | 24M | 24M | 24M | 24M | 29M |